Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT05797519
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- VDyne, Inc.
- Registry
-
NCT05797519
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Austria, Belgium, Czechia, Denmark, Germany, Netherlands, New Zealand, Spain, Sweden, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05797519. Allocation not applicable; no masking; primary purpose treatment. Start 2023-03-01 (actual); primary completion 2026-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
- Acronym
- VISTA
- Condition
- Tricuspid Regurgitation
- Condition
- Tricuspid Valve Disease
- Condition
- Tricuspid Valvular Disorders
- Intervention (Device)
- VDyne Transcatheter Tricuspid Valve Replacement System
- Lead sponsor
- VDyne, Inc.
Record details
- Record id
cardio:ct-nct05797519- Content hash
114e8cab554c1ed9e1a14a186b17b5bceadb0e0a83652bd3f622b6f496d5ab7d